{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:55:50Z","timestamp":1790999750914,"version":"4.1.0"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,10,1]]},"DOI":"10.2169\/internalmedicine.6751-25","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T22:10:40Z","timestamp":1772489440000},"page":"2604-2608","source":"Crossref","is-referenced-by-count":2,"title":["IgA Vasculitis Developing during Trastuzumab Emtansine Therapy for HER2-positive Breast Cancer"],"prefix":"10.2169","volume":"65","author":[{"given":"Nanami","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Osano","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kie","family":"Ohkoshi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Konishi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Nakada","sequence":"additional","affiliation":[{"name":"First Department of Surgery, Faculty of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ashizawa","sequence":"additional","affiliation":[{"name":"First Department of Surgery, Faculty of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Nakayama","sequence":"additional","affiliation":[{"name":"First Department of Surgery, Faculty of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mitsui","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Yamanashi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pillebout E, Sunderk\u00f6tter C. IgA vasculitis. Semin Immunopathol 43: 729-738, 2021.","DOI":"10.1007\/s00281-021-00874-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Sch\u00f6nlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 13: 1271-1278, 2002.","DOI":"10.1097\/01.ASN.0000013883.99976.22"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gonz\u00e1lez-Gay MA, L\u00f3pez-Mej\u00edas R, Pina T, Blanco R, Casta\u00f1eda S. IgA vasculitis: genetics and clinical and therapeutic management. Curr Rheumatol Rep 20: 24, 2018.","DOI":"10.1007\/s11926-018-0735-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Audemard-Verger A, Pillebout E, Guillevin L, Thervet E, Terrier B. IgA vasculitis (Henoch-Sh\u00f6nlein purpura) in adults: diagnostic and therapeutic aspects. Autoimmun Rev 14: 579-585, 2015.","DOI":"10.1016\/j.autrev.2015.02.003"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Audemard-Verger A, Pillebout E, Amoura Z, et al. Gastrointestinal involvement in adult IgA vasculitis (Henoch-Sch\u00f6nlein purpura): updated picture from a French multicentre and retrospective series of 260 cases. Rheumatology (Oxford) 59: 3050-3057, 2020.","DOI":"10.1093\/rheumatology\/keaa104"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mitsui H, Shibagaki N, Kawamura T, Matsue H, Shimada S. A clinical study of Henoch-Sch\u00f6nlein Purpura associated with malignancy. J Eur Acad Dermatol Venereol 23: 394-401, 2009.","DOI":"10.1111\/j.1468-3083.2008.03065.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sasaki K, Anderson E, Shankland SJ, Nicosia RF. Diffuse proliferative glomerulonephritis associated with cetuximab, an epidermal growth factor receptor inhibitor. Am J Kidney Dis 61: 988-991, 2013.","DOI":"10.1053\/j.ajkd.2013.01.008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bhardwaj AS, McLellan B, Robinson MR, et al. A case of vasculitis in a breast cancer patient treated with T-DM1. Semin Oncol 41: e39-e45, 2014.","DOI":"10.1053\/j.seminoncol.2014.08.010"},{"key":"9","first-page":"1732","volume":"18","author":"SL Escobar-D\u00e1vila","year":"2024","unstructured":"9. Escobar-D\u00e1vila SL, Rivas-Tafurt GP, Melo-Burbano L, et al. Report of Henoch-Sch\u00f6nlein purpura associated with trastuzumab emtansine. Ecancermedicalscience 18: 1732, 2024.","journal-title":"ecancermedicalscience","ISSN":"https:\/\/id.crossref.org\/issn\/1754-6605","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nakatani S, Mori K, Morioka F, et al. New-onset kidney biopsy-proven IgA vasculitis after receiving mRNA-1273 COVID-19 vaccine: case report. CEN Case Rep 11: 358-362, 2022.","DOI":"10.1007\/s13730-021-00677-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Abe E, Kobayashi R, Matsuoka R, et al. IgA vasculitis with nephritis accompanied by pulmonary tuberculosis: a case report. CEN Case Rep 14: 421-427, 2025.","DOI":"10.1007\/s13730-025-00966-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Rasmussen C, Tisseyre M, Garon-Czmil J, et al. Drug-induced IgA vasculitis in children and adults: revisiting drug causality using a dual pharmacovigilance-based approach. Autoimmun Rev 20: 102707, 2021.","DOI":"10.1016\/j.autrev.2020.102707"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Iriarte C, Young JH, Rabin MS, LeBoeuf NR. Osimertinib-induced cutaneous vasculitis responsive to low-dose dapsone without interruption of anticancer therapy: a case report and review of the literature. JTO Clin Res Rep 3: 100415, 2022.","DOI":"10.1016\/j.jtocrr.2022.100415"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Boll\u00e9e G, Flamant M, Schordan S, et al. Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. Nat Med 17: 1242-1250, 2011.","DOI":"10.1038\/nm.2491"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Flamant M, Boll\u00e9e G, H\u00e9nique C, Tharaux PL. Epidermal growth factor: a new therapeutic target in glomerular disease. Nephrol Dial Transplant 27: 1297-1304, 2012.","DOI":"10.1093\/ndt\/gfs030"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. von Minckwitz G, Huang CS, Mano MS, et al. Trastuzumab emtansine for residual invasive HER2-positive breast cancer. N Engl J Med 380: 617-628, 2019.","DOI":"10.1056\/NEJMoa1814017"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chang CH, Jung CJ, Huang YM, et al. The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - a case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up. Breast 61: 35-42, 2022.","DOI":"10.1016\/j.breast.2021.11.016"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Huo B, Lin L, Zhao L, Yu R, Yang J. First reported case of ANCA-associated vasculitis induced by oxaliplatin, capecitabine, and trastuzumab. Ren Fail 45: 2282710, 2023.","DOI":"10.1080\/0886022X.2023.2282710"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ozen S, Marks SD, Brogan P, et al. European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis - the SHARE initiative. Rheumatology (Oxford) 58: 1607-1616, 2019.","DOI":"10.1093\/rheumatology\/kez041"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/19\/65_6751-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:30:36Z","timestamp":1790998236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/19\/65_6751-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":19,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6751-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"6751-25"}}